Phase 1 Albumin Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Chemoradiotherapy in Unresectable Esophageal Cancer

Esophageal CancerChemoradiotherapyAlbumin-bound Paxlitaxel+1 more

Cancer Institute and Hospital, Chinese Academy of Medical Sciences105 enrolled5 locationsNCT04278287

Not Yet Recruiting

Phase 1

A Phase 1, Partially Blinded, Placebo-Controlled, Pharmacokinetic Study of Intravenously Administered BMS-943539-01-001 in Healthy Male Volunteers

Pharmacokinetics of Intravenously Administered BMS-943539 in Healthy Male Volunteers. BMS-943539 is an Adnectin (protein) which is specifically engineered to bind to Human Serum Albumin (HSA).

Bristol-Myers Squibb Australia37 enrolled1 locationACTRN12610001043022